Last reviewed · How we verify
NCT03814954
Nebulized Epinephrine vs. Salbutamol in Bronchiolitis Among Children
NA trial testing Salbutamol in Respiratory Distress Score in 90 participants. Completed in 31 August 2021.
31 August 2021
Quick facts
| Lead sponsor | Makassed General Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 1 January 2019 |
| Primary completion | 31 August 2021 |
| Estimated completion | 31 August 2021 |
| Sites | 1 location across Lebanon |
Drugs / interventions tested
- Salbutamol (salbutamol) — full drug profile →
- Epinephrine (epinephrine) — full drug profile →
Conditions studied
- Respiratory Distress Score — all drugs for Respiratory Distress Score →
Sponsor
Makassed General Hospital
Who can join
Adults 1 Month to 24 Months, any sex, with Respiratory Distress Score. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Acute bronchiolitis, mostly secondary to infection due to Respiratory syncytial virus (RSV) is very common in infants under two years old. It is usually benign. However, the dyspnea it causes is a big concern for parents and this disease can take a severe form on certain particular ground thus constituting a frequent reason for hospitalization in pediatrics. Nebulized epinephrine showed more efficacy than nebulized salbutamol.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03814954
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Salbutamol
Trials testing the same drug.
- NCT07037511 — Effects of Salbutamol in Athletes and Implications for Screening and Sports · NA · recruiting
- NCT06473779 — Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remiss · Phase 3 · active not recruiting
- NCT06276231 — Nebulized Salbutamol in Acute Renal Colic · NA · unknown
- NCT06482294 — CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma · Phase 2 · active not recruiting
- NCT05550402 — Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study) · NA · unknown
Other Makassed General Hospital trials
Trials by the same sponsor.
- NCT07201883 — Chewing Gum vs. Ondansetron as Rescue Treatment for PONV in Female Patients · Phase 1 · active not recruiting
- NCT07182110 — Dexamethasone-Enhanced TAP Block in Lapchole · Phase 1 · active not recruiting
- NCT07049835 — Ilioinguinal Nerve Block With Local Anesthetic vs. Placebo in Inguinal Hernia Repair Under Spinal Anesthesia · Phase 1 · active not recruiting
- NCT06963229 — Spinal Anesthesia Vs. Neve Block in Risk of Cognitive Decline · NA · active not recruiting
- NCT06917898 — Fentanyl Versus Midazolam as an Adjunct to Spinal Anesthesia · Phase 1 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03814954 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Makassed General Hospital
- Last refreshed: 30 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03814954.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing